Page last updated: 2024-09-04

ivabradine and Allodynia

ivabradine has been researched along with Allodynia in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (75.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Fuseya, S; Ishida, K; Ishida, T; Ito, M; Kawamata, M; Sakamoto, A; Tanaka, S	1
Laínez, S; McNaughton, PA; Mehta, I; Tsantoulas, C; Vilar, B; Wong, S	1
Armstrong, G; Bond, S; Lee, MC; McNaughton, P; Menon, D; Scholtes, I; Wheeler, D	1
Bukhanova, N; Chen, Y; Kumar, N; Noh, S; Smith, PA; Stemkowsi, PL	1

Trials

2 trial(s) available for ivabradine and Allodynia

Article	Year
A randomized, double-blinded, placebo-controlled, crossover study of the HCN channel blocker ivabradine in a capsaicin-induced pain model in healthy volunteers. Scientific reports, 2022, 10-14, Volume: 12, Issue:1 Topics: Adult; Analgesics; Calcium Channel Blockers; Capsaicin; Cross-Over Studies; Female; Healthy Volunteers; Humans; Hyperalgesia; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Male; Neuralgia; Nucleotides, Cyclic	2022
A randomised, double-blind, placebo-controlled crossover trial of the influence of the HCN channel blocker ivabradine in a healthy volunteer pain model: an enriched population trial. Pain, 2019, Volume: 160, Issue:11 Topics: Analgesics; Benzazepines; Calcium Channel Blockers; Double-Blind Method; Heart Rate; Hyperalgesia; Ivabradine; Neuralgia	2019

Article

Year

A randomized, double-blinded, placebo-controlled, crossover study of the HCN channel blocker ivabradine in a capsaicin-induced pain model in healthy volunteers.

Scientific reports, 2022, 10-14, Volume: 12, Issue:1

Topics: Adult; Analgesics; Calcium Channel Blockers; Capsaicin; Cross-Over Studies; Female; Healthy Volunteers; Humans; Hyperalgesia; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Male; Neuralgia; Nucleotides, Cyclic

2022

A randomised, double-blind, placebo-controlled crossover trial of the influence of the HCN channel blocker ivabradine in a healthy volunteer pain model: an enriched population trial.

Pain, 2019, Volume: 160, Issue:11

Topics: Analgesics; Benzazepines; Calcium Channel Blockers; Double-Blind Method; Heart Rate; Hyperalgesia; Ivabradine; Neuralgia

2019

Other Studies

2 other study(ies) available for ivabradine and Allodynia

Article	Year
Hyperpolarization-activated cyclic nucleotide-gated 2 (HCN2) ion channels drive pain in mouse models of diabetic neuropathy. Science translational medicine, 2017, Sep-27, Volume: 9, Issue:409 Topics: Analgesics; Animals; Benzazepines; Cyclic AMP; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Disease Models, Animal; Gene Deletion; Hyperalgesia; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Nociception; Pain; Potassium Channels; Proto-Oncogene Proteins c-fos; Sensory Receptor Cells; Skin; Spinal Cord Dorsal Horn; Streptozocin	2017
The heart-rate-reducing agent, ivabradine, reduces mechanical allodynia in a rodent model of neuropathic pain. European journal of pain (London, England), 2014, Volume: 18, Issue:8 Topics: Analgesics; Animals; Arterial Pressure; Benzazepines; Disease Models, Animal; Female; Heart Rate; Hyperalgesia; Ivabradine; Male; Neuralgia; Pain Measurement; Pain Threshold; Peripheral Nerve Injuries; Rats; Rats, Sprague-Dawley	2014

Article

Year

Hyperpolarization-activated cyclic nucleotide-gated 2 (HCN2) ion channels drive pain in mouse models of diabetic neuropathy.

Science translational medicine, 2017, Sep-27, Volume: 9, Issue:409

Topics: Analgesics; Animals; Benzazepines; Cyclic AMP; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Disease Models, Animal; Gene Deletion; Hyperalgesia; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Nociception; Pain; Potassium Channels; Proto-Oncogene Proteins c-fos; Sensory Receptor Cells; Skin; Spinal Cord Dorsal Horn; Streptozocin

2017

The heart-rate-reducing agent, ivabradine, reduces mechanical allodynia in a rodent model of neuropathic pain.

European journal of pain (London, England), 2014, Volume: 18, Issue:8

Topics: Analgesics; Animals; Arterial Pressure; Benzazepines; Disease Models, Animal; Female; Heart Rate; Hyperalgesia; Ivabradine; Male; Neuralgia; Pain Measurement; Pain Threshold; Peripheral Nerve Injuries; Rats; Rats, Sprague-Dawley

2014